Related Experiment Video

Updated: Aug 26, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Impairment of p53 acetylation, stability and function by an oncogenic transcription factor

Alessandra Insinga1, Silvia Monestiroli, Simona Ronzoni

  • 1Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.

The EMBO Journal
|February 21, 2004
PubMed

Insights

Acute promyelocytic leukemia (APL) fusion proteins PML-RAR and PLZF-RAR inhibit the tumor suppressor p53. This mechanism allows leukemic cells to evade cancer surveillance and promotes APL development.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Hematology

Background:

  • Mutations in the p53 tumor suppressor gene are infrequent in acute promyelocytic leukemia (APL).
  • The underlying mechanisms for p53's functional integrity in APL remain largely unknown.
  • APL is characterized by specific oncogenic fusion proteins, PML-RAR and PLZF-RAR.

Purpose of the Study:

  • To investigate the interaction between APL-associated fusion proteins and the p53 tumor suppressor.
  • To elucidate the molecular mechanisms by which p53 function is regulated in APL.
  • To determine the role of p53 inhibition in APL pathogenesis.

Main Methods:

  • Western blotting to assess p53 protein levels and modifications.
  • Immunoprecipitation assays to study protein-protein interactions.
  • Reporter gene assays to measure p53 transcriptional activity.
  • Treatment with histone deacetylase (HDAC) inhibitors or activators.

Main Results:

  • PML-RAR and PLZF-RAR fusion proteins directly inhibit p53 activity in APL cells.
  • PML-RAR induces deacetylation and degradation of p53, leading to repressed transcription.
  • Wild-type PML acts as a crucial mediator, bridging p53 and PML-RAR.
  • HDAC recruitment to p53 by PML-RAR is identified as the key mechanism for p53 inhibition.

Conclusions:

  • APL fusion proteins subvert p53 function through direct inhibition and degradation.
  • The PML-RAR-mediated inhibition of p53 is dependent on HDAC recruitment.
  • Understanding this pathway offers potential therapeutic targets for APL treatment.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.